Cargando…
Treatment with broadly neutralizing influenza antibodies reduces severity of secondary pneumococcal pneumonia in mice
Secondary bacterial pneumonia is a frequent complication of influenza, associated with high morbidity and mortality. We hypothesized that treatment with neutralizing influenza A antibody AT10_002 protects against severe secondary pneumococcal infection in a mouse model of influenza A infection. Infl...
Autores principales: | van Someren Gréve, Frank, van der Sluijs, Koenraad F., Tuip, Anita M., Schultz, Marcus J., de Jong, Menno D., Juffermans, Nicole P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055667/ https://www.ncbi.nlm.nih.gov/pubmed/29718555 http://dx.doi.org/10.1002/jmv.25212 |
Ejemplares similares
-
Novel influenza A antibodies reduce severity of secondary pneumococcal pneumonia after influenza infection in mice
por: Van der Sluijs, KF, et al.
Publicado: (2015) -
Bench-to-bedside review: Bacterial pneumonia with influenza - pathogenesis and clinical implications
por: van der Sluijs, Koenraad F, et al.
Publicado: (2010) -
Clinical practice of respiratory virus diagnostics in critically ill patients with a suspected pneumonia: A prospective observational study
por: van Someren Gréve, Frank, et al.
Publicado: (2016) -
Induced hypothermia is protective in a rat model of pneumococcal pneumonia
por: Beurskens, C, et al.
Publicado: (2011) -
Tackling influenza with broadly neutralizing antibodies
por: Corti, Davide, et al.
Publicado: (2017)